uncontrolled diabetes mellitus type 1 - Nursing Case Study

Pathophysiology

• Primary mechanism: In type 1 diabetes mellitus (T1DM), autoimmune destruction of pancreatic beta cells leads to absolute insulin deficiency, resulting in the inability to regulate blood glucose levels effectively.

• Secondary mechanism: Without insulin, glucose cannot enter cells for energy production, leading to hyperglycemia. The body responds by breaking down fats and proteins for energy, producing ketone bodies, which can lead to diabetic ketoacidosis (DKA).

• Key complication: Persistent hyperglycemia and ketonemia contribute to severe dehydration and electrolyte imbalances, potentially leading to life-threatening conditions such as cerebral edema and cardiovascular collapse if not promptly treated.

Patient Profile

Demographics:

45-year-old male, software engineer

History:

• Key past medical history: Diagnosed with type 1 diabetes mellitus at age 12, history of diabetic ketoacidosis, hypertension, and peripheral neuropathy

• Current medications: Insulin (basal-bolus regimen), Lisinopril, Gabapentin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe fatigue and recurrent episodes of dizziness

• Key symptoms: Persistent hyperglycemia, blurred vision, frequent urination, numbness and tingling in extremities, unhealing foot ulcer

• Vital signs: Blood pressure 180/110 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 99.5°F, blood glucose 350 mg/dL

Section 1

Following the initial assessment, the patient underwent a series of diagnostic tests to better understand the extent of his condition and identify any new complications. Laboratory results revealed a blood pH of 7.25, indicating metabolic acidosis consistent with diabetic ketoacidosis (DKA). Serum ketones were markedly elevated, and the anion gap was increased at 20 mmol/L, further supporting the diagnosis of DKA. Electrolyte imbalances were significant, with serum potassium at 5.8 mEq/L, reflecting a potentially dangerous shift due to acidosis, while sodium was low at 130 mEq/L, suggesting dilutional hyponatremia. These findings necessitated urgent correction to prevent the progression of complications.

Further imaging studies, including a Doppler ultrasound of the lower extremities, revealed decreased blood flow in the right foot, raising concerns for critical limb ischemia secondary to the unhealing foot ulcer and peripheral neuropathy. An MRI of the brain was performed due to the patient’s severe dizziness and blurred vision, which ruled out cerebral edema but did indicate small vessel ischemic changes, likely a result of chronic hypertension and poorly controlled diabetes. These findings underscore the importance of aggressive management of both blood pressure and glucose levels to mitigate further vascular damage.

The clinical team, considering the complexity of the case, initiated an advanced management plan. Intravenous insulin therapy was commenced to address hyperglycemia and DKA, along with careful electrolyte repletion to manage potassium and sodium levels. The patient was also started on an IV fluid regimen to correct dehydration. Given the vascular complications, a vascular surgery consult was requested to evaluate the need for potential revascularization of the affected limb. This approach aimed to stabilize the patient's acute condition while addressing underlying chronic complications, facilitating a comprehensive and multifaceted treatment strategy. As the patient’s condition evolves, continuous monitoring and reassessment will be crucial to adjust the treatment plan and prevent further deterioration.

Section 2

As the advanced management plan was implemented, the patient's response to interventions provided both encouraging signs and new challenges, highlighting the intricate interplay of his complex condition. Within the first 24 hours of initiating intravenous insulin therapy, there was a notable improvement in blood glucose levels, which decreased from an initial 450 mg/dL to 230 mg/dL. However, as insulin facilitated the intracellular shift of potassium, serum potassium levels fell rapidly to 3.2 mEq/L, necessitating urgent potassium repletion to prevent the risk of hypokalemia-induced cardiac arrhythmias. Despite aggressive fluid resuscitation, the patient’s sodium levels remained low at 132 mEq/L, requiring careful adjustment of fluid composition to avoid rapid shifts that could precipitate central pontine myelinolysis.

Simultaneously, the vascular surgery team evaluated the patient for critical limb ischemia. The decreased blood flow in the right foot, coupled with the unhealing ulcer, prompted an urgent consideration for endovascular intervention. An angiography was scheduled to assess the feasibility of a balloon angioplasty to restore perfusion. However, the patient began to exhibit new symptoms of increased pain and pallor in the affected limb, alongside a drop in ankle-brachial index to 0.5, indicating worsening ischemia despite medical management. This development required immediate escalation in care to prevent limb loss, emphasizing the need for timely surgical intervention.

Throughout this period, continuous monitoring revealed fluctuating vital signs, including episodes of tachycardia at 110 bpm and hypotension with blood pressures ranging from 90/60 mmHg to 100/70 mmHg, reflective of underlying autonomic neuropathy and volume status changes. These hemodynamic shifts underscored the necessity for vigilant adjustment of fluid and electrolyte therapy, alongside close cardiac monitoring. The evolving clinical scenario demanded rigorous reassessment and coordination among multidisciplinary teams to navigate the complexities of the patient's deteriorating condition, paving the way for the next critical steps in his care continuum.

Section 3

As the multidisciplinary team continued to manage the patient’s complex presentation, new diagnostic results further complicated the clinical picture. A repeat complete blood count revealed a white blood cell count of 15,000 cells/mm³, suggesting a potential infectious process, likely related to the unhealing ulcer on the right foot. This prompted the initiation of broad-spectrum antibiotics, with plans to de-escalate based on culture and sensitivity results. Meanwhile, a blood gas analysis showed a mixed acid-base disorder with a pH of 7.32, a bicarbonate level of 18 mEq/L, and a partial pressure of carbon dioxide (pCO2) of 32 mmHg, indicating a state of compensated metabolic acidosis likely due to ongoing diabetic ketoacidosis and possible lactic acidosis from tissue ischemia.

In light of these findings, the patient’s clinical status experienced a significant change. His mental status fluctuated, with episodes of confusion and lethargy, raising concerns about cerebral perfusion and the potential onset of cerebral edema, a rare but serious complication of rapid correction of hyperglycemia. Neurological assessments revealed sluggish pupillary reactions and a mild right-sided weakness, necessitating an urgent CT scan of the head to rule out any acute intracranial event. Furthermore, despite adjustments in insulin therapy, his blood glucose levels began to rise again, reaching 280 mg/dL, indicating a need for reevaluation of his insulin regimen and consideration of contributing factors such as infection and stress response.

The patient’s evolving condition underscored the critical need for continuous reassessment and dynamic adjustment of therapeutic strategies. As the team prepared for the next phase of management, including potential surgical intervention for limb ischemia and further titration of electrolyte and fluid therapy, the focus remained on stabilizing the patient’s hemodynamics and preventing further deterioration. These complexities highlighted the intricate balance required in managing such a multifaceted case, necessitating advanced critical thinking and seamless collaboration across the care team.

Section 4

As the team continued to grapple with the complexities of the patient's condition, new diagnostic results emerged that further complicated the clinical picture. An MRI of the brain, performed to evaluate the altered mental status and neurological signs, revealed diffuse cerebral edema without evidence of acute hemorrhagic or ischemic stroke. This finding was consistent with osmotic shifts secondary to rapid changes in blood glucose levels, necessitating a delicate approach to managing the patient's hyperglycemia and fluid status to prevent further neurological compromise.

Additionally, cultures of the unhealing foot ulcer returned, identifying a multidrug-resistant organism, Methicillin-resistant Staphylococcus aureus (MRSA), necessitating a change in antibiotic therapy to vancomycin. This change required close monitoring of renal function due to the nephrotoxic potential of the drug, especially in the context of the patient's ongoing metabolic acidosis and potential lactic acidosis. The patient's blood pressure had also become labile, with episodes of hypotension alternating with hypertension, indicating possible autonomic dysregulation and a need for careful titration of fluid resuscitation and vasopressor support.

The patient's clinical status continued to be closely monitored, with an emphasis on preventing further deterioration. The team considered the possibility of initiating continuous renal replacement therapy (CRRT) to manage the metabolic acidosis and support renal function in the setting of antibiotic therapy. As the team prepared for potential surgical intervention to address the limb ischemia, a vascular surgery consult was obtained to evaluate the risk-benefit ratio in the context of the patient's unstable condition. The evolving scenario required advanced critical thinking and a collaborative approach to navigate the multifaceted challenges effectively and ensure the best possible outcome for the patient.

Section 5

As the multidisciplinary team continued to manage the complexities of the patient’s condition, a significant change in patient status was observed. Overnight, the patient's neurological status deteriorated further, with a marked decline in Glasgow Coma Scale (GCS) score from 11 to 8, indicating a progression towards severe encephalopathy. Concurrently, the patient developed signs of acute respiratory distress, with an increased respiratory rate of 32 breaths per minute and oxygen saturation dropping to 88% on high-flow oxygen, necessitating urgent intubation and mechanical ventilation to protect the airway and support respiratory function.

Laboratory tests revealed worsening metabolic derangements. The patient’s serum lactate levels increased to 6.8 mmol/L, indicative of profound lactic acidosis, while arterial blood gas analysis showed a pH of 7.18, bicarbonate level of 12 mEq/L, and a base excess of -14, suggesting severe acidosis. The patient's renal function also further declined, with serum creatinine rising to 3.5 mg/dL and urine output decreasing to 15 mL/hr over the past four hours, confirming acute kidney injury likely exacerbated by vancomycin therapy and systemic inflammation.

In light of these developments, the team decided to initiate continuous renal replacement therapy (CRRT) to address the severe metabolic acidosis and support the failing renal function. This intervention aimed to stabilize the patient's internal environment, allowing time for antibiotics to address the MRSA infection and potentially improve cerebral edema by managing fluid overload. Given the patient's critical status, the team prioritized the careful monitoring of hemodynamics, ensuring that fluid resuscitation and vasopressor support were tailored to maintain adequate cerebral perfusion pressure and organ perfusion. The evolving clinical scenario underscored the need for vigilant reassessment and a dynamic approach to treatment, with the goal of stabilizing the patient for potential surgical intervention to address limb ischemia once the acute metabolic and respiratory crises were managed.